Atossa Genetics (ATOS) PT Raised to $7.50 at Ascendiant Capital
Tweet Send to a Friend
Ascendiant Capital analyst Edward Woo raised the price target on Atossa Genetics (NASDAQ: ATOS) to $7.50 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
